反意义分子:一种有希望的新疗法,用于治疗亚托邦性皮肤炎
Jiayi Xue1,2, Zhirong Yao1,2
1Department of Dermatology, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200092, China.
Acta pharmaceutica Sinica. B
|November 28, 2025
概括
反感性RNA疗法通过向疾病机制,为治疗亚托皮炎 (AD) 提供了一种新的方法. 这种方法对修改AD有希望,超越症状管理以获得更好的患者结果.
科学领域:
- 皮肤病学 皮肤病学
- 遗传学 遗传学 是一个
- 药理学 药理学是指药理学的学科.
背景情况:
- 无氧性皮肤炎 (AD) 是一种广泛的,慢性皮肤疾病,影响所有年龄段的人,特别是儿童,全球流行率很高.
- 目前的阿尔茨海默病治疗侧重于症状管理,而不是疾病修饰,强调需要创新的治疗策略.
- 针对RNA的疗法,就像反意义分子一样,正在彻底改变精密医学,在其他疾病中得到了成功的应用.
研究的目的:
- 审查反意义技术作为亚托皮性皮肤炎的新疗法范式的潜力.
- 检查使用反意义分子来准AD病变的背后的机械逻辑.
- 讨论在AD管理中基于RNA的疗法的转化挑战和临床潜力.
主要方法:
- 审查关于RNA向疗法的现有文献,特别是关于在亚托皮性皮肤炎的背景下使用反感性分子.
- 对反感疗法所针对的转录后调节机制的分析.
- 检查概念验证研究和早期临床试验,涉及基于反意义的AD治疗.
主要成果:
- 反意义疗法可以实现转录后基因调节,向参与AD的信使RNA (mRNA) 和非编码RNA (ncRNA).
- 皮肤的可访问性使其成为反感应调制的合适目标.
- 有希望的概念验证结果和正在进行的临床试验表明了反意义技术在阿尔茨海默病中的潜力.
结论:
- 反意义技术代表了亚托皮炎管理的范式转变,与更广泛的RNA疗法革命保持一致.
- 这种方法提供了疾病修饰的潜力,而不仅仅是AD的症状缓解.
- 克服转化挑战对于实现AD治疗中反意义疗法的全部临床潜力至关重要.
关键词:
反意义分子是一种反意义分子.亚托邦性皮肤炎 (Atopic Dermatitis) 是一种不良的疾病.临床翻译 临床翻译临床试验中的临床试验.疾病的修饰 疾病的修饰药物开发 药物开发基因治疗是一种基因疗法.精准医学是一门精准的医学.临床前测试 临床前测试在RNA疗法中使用RNA疗法.更多相关视频
09:04Sequence-specific and Selective Recognition of Double-stranded RNAs over Single-stranded RNAs by Chemically Modified Peptide Nucleic Acids
Published on: September 21, 2017
9.9K
09:42Development of an Economical DNA Delivery System by "Acufection" and its Application to Skin Research
Published on: April 19, 2017
7.8K
相关概念视频
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
1.7K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.7K
01:19Antiasthma Drugs: Leukotriene Modifiers
1.7K
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
1.7K
02:15Experimental RNAi
7.2K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
7.2K
02:30siRNA - Small Interfering RNAs
18.3K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
18.3K
01:19Clinical Applications of Epidermal Stem Cells
3.2K
Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
3.2K